Humana Inc
HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 9/3040% above fair value
$410.41−4.09 (-0.99%)
Close on Nov 2, 2026Market cap $49.28BP/E 38.7Yield 0.86%
Humana CenterWell Pharmacy by Quarter
CenterWell Pharmacy — Total Medicare Generic Dispense Rate (%) (%)
Humana CenterWell Pharmacy: 90.6% in Q2 2026, down 0.1 pts from a year earlier.
Latest, Q2 2026
90.6%
Period ended Jun 30, 2026
Change on a year earlier
-0.1 pts
90.7% in Q2 2025
History
19 quarters
Since Q4 2021
Sources
15
Documents cited below
Where the Q2 2026 figure comes from
“|| Total Medicare | 90.6 | % | 90.8 | % | 90.7 | % | 90.8 | % | 91.0 | %”
Source: HUM Form 8-K Statistical Supplement (2026-07-29) ↗
Reported in HUM SEC Filings (8-K Statistical Supplement / 10-K / DEF 14A).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up centerWell Pharmacy
- CenterWell Pharmacy — Total Medicare Mail-Order Penetration (%)23.8% · Q2 2026
- Pharmacy Script Volume — 30-Day Equivalent Scripts (k, legacy pre-2022)134,000 · Q3 2022
- Retail Segment Generic Dispense Rate (%, legacy pre-2022)91.6% · Q3 2022
- Retail Segment Mail-Order Penetration (%, legacy pre-2022)30.7% · Q3 2022
Cite this data
StockData. (2026). Humana CenterWell Pharmacy (%), quarterly Q4 2021–Q2 2026 [Data set]. Compiled from Humana SEC filings and investor materials. https://stockdatahq.com/stocks/hum/kpis/cw-rx-gdr-medicare-pct
See every metric in the Humana KPI table. Data updated Nov 2, 2026.